Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-2.59%)
Close on Nov 17, 2026Market cap $1.96MP/E –Yield –
Jaguar Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Jaguar Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.69M. For fiscal 2025 it was -$23.69M. The highest annual figure on record is -$5.36M in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.69M | – |
| FY2024 | Dec 31, 2024 | -$29.38M | – |
| FY2023 | Dec 31, 2023 | -$33.24M | – |
| FY2022 | Dec 31, 2022 | -$33.10M | – |
| FY2021 | Dec 31, 2021 | -$34.97M | – |
| FY2020 | Dec 31, 2020 | -$15.28M | – |
| FY2019 | Dec 31, 2019 | -$20.46M | – |
| FY2018 | Dec 31, 2018 | -$22.73M | – |
| FY2017 | Dec 31, 2017 | -$9.82M | – |
| FY2016 | Dec 31, 2016 | -$14.41M | – |
| FY2015 | Dec 31, 2015 | -$14.32M | – |
| FY2014 | Dec 31, 2014 | -$5.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.34M | – |
| Q1 FY2026 | Mar 31, 2026 | $8.83M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.49M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.69M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.20M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.31M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.83M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.34M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.17M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.05M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.79M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.95M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.42M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.46M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.43M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.91M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.71M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.00M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.30M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.14M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.55M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.31M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.47M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.90M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.81M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.33M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.03M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.18M | – |
| Q1 FY2017 | Mar 31, 2017 | -$288.72K | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.73M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.38M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.78M | – |
See a number that looks wrong?